CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Oncotarget. 2018 Sep 28;9(76):34193-34195. doi: 10.18632/oncotarget.26134.
No abstract available

Keywords: CDK4/6 inhibitors; hormone receptor-positive; metastatic breast cancer.

Publication types

  • Editorial